![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 19, 16383-16390, May 10, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
From the Institut für Molekularbiologie und Tumorforschung
(IMT), Philipps-Universität, E.-Mannkopff-Str. 2, D-35033 Marburg, Germany
We have addressed the functional significance of
the existence of several natural splice variants of NF1-C* differing in
their COOH-terminal proline-rich transactivation domain (PRD) by
studying their specific DNA binding and transactivation in the yeast
Saccharomyces cerevisiae. These parameters yielded the
intrinsic transactivation potential (ITP), defined as the activation
observed with equal amounts of DNA bound protein. Exchange of 83 amino
acids at the COOH-terminal end of the PRD by 16 unrelated amino acids,
as found in NF1-C2, and splicing out the central region of the PRD, as found in NF1-C7, enhanced DNA binding in vivo and in
vitro. However, the ITP of the splice variants NF1-C2 and NF1-C7
was found to be similar to that of the intact NF1-C1. Additional
mutations showed that the ITP of NF1-C requires the synergistic action
of the PRD and a novel domain encoded in exons 5 and 6. Intriguingly the carboxyl-terminal domain-like motif encoded in exons 9/10 is not
essential for transactivation of a reporter with a single NF1 site but
is required for activation of a reporter with six NF1 sites in tandem.
Our results imply that differential splicing is used to regulate
transcription by generating variants with different DNA binding
affinities but similar ITPs.
Present address: Departamento de Genética, Universidad de
Sevilla, Apartado 1095, E-41080 Sevilla, Spain.
§
To whom correspondence should be addressed. Tel.: 49-6421-286-6286;
Fax: 49-6421-286-5398; E-mail: beato@imt.uni-marburg.de.
This article has been cited by other articles:
![]() |
J. Kim, S. Sharma, Y. Li, E. Cobos, J. J. Palvimo, and S. C. Williams Repression and Coactivation of CCAAT/Enhancer-binding Protein {epsilon} by Sumoylation and Protein Inhibitor of Activated STATx Proteins J. Biol. Chem., April 1, 2005; 280(13): 12246 - 12254. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Belikov, C. Astrand, P.-H. Holmqvist, and O. Wrange Chromatin-Mediated Restriction of Nuclear Factor 1/CTF Binding in a Repressed and Hormone-Activated Promoter In Vivo Mol. Cell. Biol., April 1, 2004; 24(7): 3036 - 3047. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Wickenheisser, V. L. Nelson-DeGrave, P. G. Quinn, and J. M. McAllister Increased Cytochrome P450 17{alpha}-Hydroxylase Promoter Function in Theca Cells Isolated from Patients with Polycystic Ovary Syndrome Involves Nuclear Factor-1 Mol. Endocrinol., March 1, 2004; 18(3): 588 - 605. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |